Compound class:
Synthetic organic
Comment: LEI-800 is the optimized lead from a novel class of isoquinoline sulfonamide antibacterial compounds [2]. The compound inhibits bacterial DNA gyrase and has activity against clinically relevant Gram-negative bacteria.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Alt S, Mitchenall LA, Maxwell A, Heide L. (2011)
Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. J Antimicrob Chemother, 66 (9): 2061-9. [PMID:21693461] |
2. Bakker AT, Kotsogianni I, Avalos M, Punt JM, Liu B, Piermarini D, Gagestein B, Slingerland CJ, Zhang L, Willemse JJ et al.. (2024)
Discovery of isoquinoline sulfonamides as allosteric gyrase inhibitors with activity against fluoroquinolone-resistant bacteria. Nat Chem, 16 (9): 1462-1472. [PMID:38898213] |
3. Maxwell A. (1999)
DNA gyrase as a drug target. Biochem Soc Trans, 27 (2): 48-53. [PMID:10093705] |